Sinopharm Tech (08156) released its annual performance, with a net loss attributable to shareholders of HKD 19.698 million, an 85.2% increase year-on-year.

SINOPHARM TECH (08156) announced its financial results for the year ending June 30, 2024, with operating revenue of HK$41.277 million, a decrease of 3.6% year-on-year. The company's attributable loss was HK$19.698 million, an increase of 85.2% year-on-year, resulting in a basic loss per share of HK$0.11. The decrease in revenue during the period was attributed to the discontinuation of manufacturing and distribution of personal protective equipment businesses, as the resumption of social activities led to a decrease in market demand for personal protective equipment. Furthermore, the company has applied to resume trading of its shares from 9:00 am on December 24, 2024, after the publication of this announcement.